Viridian Therapeutics schedules third-quarter financial results release

VRDN•2026-10-20

Viridian Therapeutics will report third-quarter 2026 results before markets open on November 4 and host a conference call at 8 a.m. ET.

1. Results and call scheduled

Viridian Therapeutics will release its third-quarter 2026 financial results before the market opens on November 4. Management will host a conference call at 8 a.m. ET that day to discuss the results and provide a business update.

Viridian Therapeutics schedules third-quarter financial results release

1. Results and call scheduled

Related News

Toro names Neal M. Lackritz chief technology officer, effective Nov. 2, 2026

United Airlines forecasts fourth-quarter adjusted diluted EPS of $0.50-$1.50

Entravision appoints Gary Ferrera, Brian Krzanich to board

4D Molecular Therapeutics Chief Legal Officer Scott Bizily reports sale of $20,993.40 in common shares

Claros Mortgage Trust publishes update to financial calendar